Investigational Site Number 8402033 — Opa-locka, Florida

Investigational Site Number 8402033 is a clinical research site located in Opa-locka, Florida, United States 33054.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 8402033 has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Lexicon Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Opa-locka

Browse all research sites in Florida · View every site in Opa-locka

• Sunshine Research Center
• Research Site
• Pfizer Investigational Site
• 234, Novartis Investigational Site
• 84005 Sunshine Research Center
• GSK Investigational Site
• Furiex research site
• Forest Investigative Site 1232
• Investigational Site Number 8400106
• GSK Clinical Trials Call Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 8402033?

Investigational Site Number 8402033 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 8402033 conducted?

Investigational Site Number 8402033 has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Investigational Site Number 8402033 accredited by Crixeo Clinical Trials?

Investigational Site Number 8402033 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 8402033?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.